JP2016003187A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016003187A5 JP2016003187A5 JP2014122464A JP2014122464A JP2016003187A5 JP 2016003187 A5 JP2016003187 A5 JP 2016003187A5 JP 2014122464 A JP2014122464 A JP 2014122464A JP 2014122464 A JP2014122464 A JP 2014122464A JP 2016003187 A5 JP2016003187 A5 JP 2016003187A5
- Authority
- JP
- Japan
- Prior art keywords
- schizophrenia
- bifidobacterium
- therapeutic agent
- active ingredient
- genus bacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000000980 schizophrenia Diseases 0.000 claims description 7
- 241000186000 Bifidobacterium Species 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 241001608472 Bifidobacterium longum Species 0.000 claims description 3
- 229940009291 Bifidobacterium longum Drugs 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims 3
- 235000013361 beverage Nutrition 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014122464A JP6234331B2 (ja) | 2014-06-13 | 2014-06-13 | 統合失調症治療剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014122464A JP6234331B2 (ja) | 2014-06-13 | 2014-06-13 | 統合失調症治療剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016003187A JP2016003187A (ja) | 2016-01-12 |
| JP2016003187A5 true JP2016003187A5 (es) | 2016-12-28 |
| JP6234331B2 JP6234331B2 (ja) | 2017-11-22 |
Family
ID=55222737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014122464A Active JP6234331B2 (ja) | 2014-06-13 | 2014-06-13 | 統合失調症治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6234331B2 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2017130859A1 (ja) * | 2016-01-28 | 2018-11-15 | 森永乳業株式会社 | 神経細胞死抑制剤 |
| JP2023511678A (ja) * | 2020-01-24 | 2023-03-22 | 森永乳業株式会社 | 神経突起伸長改善用組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006097949A1 (en) * | 2005-03-16 | 2006-09-21 | Actial Farmacêutica, Lda. | Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough |
| EP2110028A1 (en) * | 2008-04-15 | 2009-10-21 | Nestec S.A. | Bifidobacterium longum and hippocampal BDNF expression |
| JP2012529272A (ja) * | 2009-06-11 | 2012-11-22 | アンジオケム インコーポレーテッド | Ｇｄｎｆおよびｂｄｎｆを中枢神経系へ送達するための融合タンパク質 |
| EP2308499A1 (en) * | 2009-09-30 | 2011-04-13 | Nestec S.A. | Bifidobacterium longum ATCC BAA-999 (BL999) and weight control |
| CN103037875B (zh) * | 2009-11-11 | 2014-11-05 | 食物营养健康有限公司 | 双歧杆菌菌株 |
| ES2581843T3 (es) * | 2010-10-07 | 2016-09-07 | California Institute Of Technology | Terapias probióticas para el autismo |
| JP5774517B2 (ja) * | 2012-02-22 | 2015-09-09 | 森永乳業株式会社 | ビフィドバクテリウム属細菌含有発酵食品の製造方法 |
-
2014
- 2014-06-13 JP JP2014122464A patent/JP6234331B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2016086210A8 (en) | Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease | |
| AR110684A1 (es) | Composiciones que comprenden cepas bacterianas y método de tratamiento | |
| MX2016014807A (es) | Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados. | |
| MY186217A (en) | Mixture of hmos | |
| WO2014018596A3 (en) | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides | |
| MX2019014045A (es) | Composiciones y metodos. | |
| WO2015114666A3 (en) | Treatments for resistant acne | |
| HK1254897A1 (zh) | 用於治療由痤瘡丙酸桿菌引起的感染尤其是痤瘡的乳酸菌的組合物 | |
| WO2015047941A3 (en) | Compositions and methods for treatment and prophylaxis of gastrointestinal diseases | |
| IN2012DN01638A (es) | ||
| EA201992176A1 (ru) | Пробиотические молекулы для снижения вирулентности патогена | |
| EP4299122A3 (en) | Compositions and methods for treating skin and mucous membrane diseases | |
| BR112017010475A2 (pt) | cepas de lactobacillus ou bifidobacterium para manter homeostase | |
| GB2511993A (en) | Prebiotic formulations and methods of use | |
| MX2023000796A (es) | Composicion farmaceutica, metodos para tratamiento y sus usos. | |
| WO2017022962A8 (ko) | Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
| EA201992175A1 (ru) | Композиции и способы, включающие пробиотические молекулы | |
| PH12019501439A1 (en) | Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus | |
| TN2016000435A1 (en) | Novel macrocyclic compounds. | |
| PH12016501988A1 (en) | Antibacterial compounds | |
| WO2016057413A3 (en) | Inhibitors of lysine gingipain | |
| PH12016501371A1 (en) | Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same | |
| WO2016100615A3 (en) | Methods and composition for neutralization of influenza | |
| JP2016003187A5 (es) | ||
| EA201291440A1 (ru) | Пробиотические штаммы для применения при повышении трансэпителиального сопротивления |